Circulating cell-free DNA levels in Portuguese patients with psoriasis vulgaris according to severity and therapy

British Journal of Dermatology

Volumn 170, Issue 4, 2014, Pages 939-942

  Coimbra, S ^a,b   Catarino, C ^a,c   Costa, E ^a,c   Oliveira, H ^d   Figueiredo, A ^d   Rocha Pereira, P ^a,e   Santos Silva, A ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b INSTITUTO DE INVESTIGAÇÃO E FORMAÇÃO AVANÇADA EM CIÊNCIAS E TECNOLOGIAS DA SAÚDE   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^e UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; PSORALEN; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; DERMATOLOGICAL AGENT; DNA;

ADULT; ARTICLE; CELL FREE SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NARROWBAND ULTRAVIOLET LIGHT B RADIATION; OUTCOME ASSESSMENT; PORTUGAL; PRIORITY JOURNAL; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; PUVA; TREATMENT DURATION; ULTRAVIOLET B RADIATION; CASE CONTROL STUDY; METABOLISM; PHOTOTHERAPY; PSORIASIS; SEVERITY OF ILLNESS INDEX;

ADULT; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DERMATOLOGIC AGENTS; DNA; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; PSORIASIS; PUVA THERAPY; SEVERITY OF ILLNESS INDEX; ULTRAVIOLET THERAPY;

EID: 84903522335     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12738     Document Type: Article

References (15)

1. Rocha-Pereira P, Santos-Silva A, Rebelo I, et al,. The inflammatory response in mild and in severe psoriasis. Br J Dermatol 2004; 150: 917-28.
2. Chodorowska G, Wojnowska D, Juszkiewicz-Borowiec M,. C-reactive protein and alpha2-macroglobulin plasma activity in medium-severe and severe psoriasis. J Eur Acad Dermatol Venereol 2004; 18: 180-3.
3. Coimbra S, Oliveira H, Reis F, et al,. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol 2010; 24: 789-96.
4. Coimbra S, Oliveira H, Reis F, et al,. Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-alpha levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy. Br J Dermatol 2010; 163: 1282-90.
5. Lo YM, Rainer TH, Chan LY, et al,. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000; 46: 319-23.
6. Lam NY, Rainer TH, Wong LK, et al,. Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24 h of symptom onset. Resuscitation 2006; 68: 71-8.
7. Tovbin D, Novack V, Wiessman MP, et al,. Circulating cell-free DNA in hemodialysis patients predicts mortality. Nephrol Dial Transplant 2012; 27: 3929-35.
8. Kohlova M, Ribeiro S, do Sameiro-Faria M, et al,. Circulating cell-free DNA levels in hemodialysis patients and its association with inflammation, iron metabolism, and rhEPO doses. Hemodial Int 2013; 17: 664-7.
9. Coimbra S, Oliveira H, Reis F, et al,. Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy. J Eur Acad Dermatol Venereol 2010; 24: 1386-94.
10. Goldshtein H, Hausmann MJ, Douvdevani A,. A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids. Ann Clin Biochem 2009; 46 (Pt 6): 488-94.
11. Frederiksson T, Pettersson U,. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44.
12. Atamaniuk J, Kopecky C, Skoupy S, et al,. Apoptotic cell-free DNA promotes inflammation in haemodialysis patients. Nephrol Dial Transplant 2012; 27: 902-5.
13. Lebwohl M, Ali S,. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol 2001; 45: 487-98; quiz 499-502.
14. Coimbra S, Oliveira H, Neuparth MJ, et al,. Inflammatory markers of cardiovascular disease risk in Portuguese psoriatic patients: relation with narrow-band ultraviolet B and psoralen plus ultraviolet A. Int J Dermatol 2014; 53: 393-6.
15. Naldi L, Gambini D,. The clinical spectrum of psoriasis. Clin Dermatol 2007; 25: 510-18.